Vorsitz: A. Götte (Paderborn), D. Thomas (Heidelberg)
| Ventricular arrhythmia: Basis insights | ||
| 12:00 | (V9) | - Molecular features of ischemia-induced VT |
| F. R. Heinzel (Berlin) | ||
| 12:20 | (V10) | - Electrophysiological mechanisms of unstable and polymorphic VT |
| R. ter Bekke (Maastricht, NL) | ||
| Debate: State-of-the-art in antiarrhythmic VT therapy | ||
| 12:40 | (V11) | - Position 1: Antiarrhythmic drugs are the mainstay of therapy in ICD patients |
| L. Eckardt (Münster) | ||
| 13:00 | (V12) | - Position 2: Catheter ablation should be the primary approach in VT therapy |
| D. Steven (Köln) | ||
| 13:20 | Final discussion |
